array:24 [
  "pii" => "S2173511509701320"
  "issn" => "21735115"
  "doi" => "10.1016/S2173-5115(09)70132-0"
  "estado" => "S300"
  "fechaPublicacion" => "2009-05-01"
  "aid" => "70132"
  "copyright" => "Sociedade Portuguesa de Pneumologia"
  "copyrightAnyo" => "2009"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "cor"
  "cita" => "Rev Port Pneumol. 2009;15:555-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3338
    "formatos" => array:3 [
      "EPUB" => 188
      "HTML" => 1786
      "PDF" => 1364
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2173511509701332"
    "issn" => "21735115"
    "doi" => "10.1016/S2173-5115(09)70133-2"
    "estado" => "S300"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "70133"
    "copyright" => "Sociedade Portuguesa de Pneumologia"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "cor"
    "cita" => "Rev Port Pneumol. 2009;15:560-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3360
      "formatos" => array:3 [
        "EPUB" => 180
        "HTML" => 1807
        "PDF" => 1373
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008&#59; 14(6):803–827"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "560"
          "paginaFinal" => "566"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Ara&#250;jo A&#44; <span class="elsevierStyleItalic">et al</span>&#46; Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ant&#243;nio Ara&#250;jo"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Ant&#243;nio"
              "apellidos" => "Ara&#250;jo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511509701332?idApp=UINPBA00004E"
    "url" => "/21735115/0000001500000003/v1_201305151509/S2173511509701332/v1_201305151509/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173511509701319"
    "issn" => "21735115"
    "doi" => "10.1016/S2173-5115(09)70131-9"
    "estado" => "S300"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "70131"
    "copyright" => "Sociedade Portuguesa de Pneumologia"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "cor"
    "cita" => "Rev Port Pneumol. 2009;15:553-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2268
      "formatos" => array:3 [
        "EPUB" => 205
        "HTML" => 1127
        "PDF" => 936
      ]
    ]
    "pt" => array:7 [
      "idiomaDefecto" => true
      "titulo" => "Carta ao Editor"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "553"
          "paginaFinal" => "554"
        ]
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Maria Jo&#227;o Marques Gomes"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Maria Jo&#227;o"
              "apellidos" => "Marques Gomes"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511509701319?idApp=UINPBA00004E"
    "url" => "/21735115/0000001500000003/v1_201305151509/S2173511509701319/v1_201305151509/pt/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Ara&#250;jo A&#44; et al&#46; An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "555"
        "paginaFinal" => "559"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Wojciech Bartminski"
        "autores" => array:1 [
          0 => array:3 [
            "preGrado" => "MD MSc"
            "nombre" => "Wojciech"
            "apellidos" => "Bartminski"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "European Outcomes Research&#44; Health Outcomes Scientist&#44; Oncology &#38; Neuroscience&#44; EMS AREA"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Ara&#250;jo A&#44; <span class="elsevierStyleItalic">et al</span>&#46; Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography&#47;Bibliografia"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:15 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:1 [
                            0 => "A&#46; Araujo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Rev Port Pneumol"
                        "fecha" => "2008"
                        "volumen" => "14"
                        "numero" => "6"
                        "paginaInicial" => "803"
                        "paginaFinal" => "827"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19023496"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Peterson P&#44; <span class="elsevierStyleItalic">et al</span>&#46; Is pemetrexed more effective in patients with non-squamous histology&#63; A retrospective analysis of a phase III trial of pemetrexed <span class="elsevierStyleItalic">vs</span>&#46; docetaxel in previously treated patients with advanced nonsmall cell lung cancer &#40;NSCLC&#41;&#46; Abstract P&#35;6521&#44; The European Cancer Conference 2007 &#40;ECCO 14&#41;&#46; Eur J Cancer 2007&#59;5 &#40;Suppl 4&#41;&#58;363&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Drummond M&#44; Sculpher M&#44; Torrance G&#44; <span class="elsevierStyleItalic">et al</span>&#46; Methods for the economic evaluation of health care programmes&#46; Oxford Medical Publications&#59; Third edition&#44; 200&#59; 48-51&#44; 121&#8211;124&#44; 190&#8211;196&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Validity of indirect comparison for estimating efficacy of competing interventions&#58; empirical evidence from published meta-analyses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:1 [
                            0 => "F&#46; Song"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.326.7387.472"
                      "Revista" => array:6 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2003"
                        "volumen" => "326"
                        "numero" => "7387"
                        "paginaInicial" => "472"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12609941"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Indirect comparisons of competing interventions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;M&#46; Glenny"
                            1 => "D&#46;G&#46; Altman"
                            2 => "F&#46; Song"
                            3 => "C&#46; Sakarovitch"
                            4 => "J&#46;J&#46; Deeks"
                            5 => "R&#46; D&#8217;Amico"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Health Technol Assess"
                        "fecha" => "2005"
                        "volumen" => "9"
                        "numero" => "26"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "da Silva AE&#44; <span class="elsevierStyleItalic">et al</span>&#46; Orienta&#231;&#245;es metodol&#243;gicas para estudos de avalia&#231;&#227;o econ&#243;mica de medicamentos&#46; INFARMED 1998 <a class="elsevierStyleInterRef" href="http://www.infarmed.pt/portal/page/portal/infarmed/medicamentos_uso_humano/ava%20liacao_economica_e_comparticipacao/medicamen%20tos_uso_ambulatorio/avaliacao_de_comparticipacao/orien_metodologicas_eaem.pdf">http&#58;&#47;&#47;www&#46;infarmed&#46;pt&#47;portal&#47;page&#47;portal&#47;infarmed&#47;medicamentos&#95;uso&#95;humano&#47;avaliacao&#95;economica&#95;e&#95;comparticipacao&#47;medicamentos&#95;uso&#95;ambulatorio&#47;avaliacao&#95;de&#95;comparticipacao&#47;orien&#95;metodologicas&#95;eaem&#46;pdf</a>&#46;"
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Product Assessment Report &#40;EPAR&#41; and Product Information&#58; Alimta&#46; CHMP 2008 <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/humandocs/Humans/EPAR/al%20imta/alimta.htm">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;Humans&#47;EPAR&#47;al imta&#47;alimta&#46;htm</a>&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Product Assessment Report &#40;EPAR&#41; and Product Information&#58; Tarceva&#46; CHMP 2008 <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/humandocs/Humans/EPAR/tarceva/tarceva.htm">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;Humans&#47;EPAR&#47;tarceva&#47;tarceva&#46;htm</a>&#46;"
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Product Assessment Report &#40;EPAR&#41; and Product Information&#58; Taxotere&#46; CHMP 2008 <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/humandocs/Humans/EPAR/tax%20otere/taxotere.htm">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;Humans&#47;EPAR&#47;tax otere&#47;taxotere&#46;htm</a>&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "N&#46; Hanna"
                            1 => "F&#46;A&#46; Shepherd"
                            2 => "F&#46;V&#46; Fossela"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2004.08.163"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol"
                        "fecha" => "2004"
                        "volumen" => "22"
                        "paginaInicial" => "1589"
                        "paginaFinal" => "1597"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15117980"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "NICE Technology Appraisal TA162&#46; November 2008&#46; Erlotinib for the treatment of non-small cell lung cancer&#46; Pages 11-12 <a class="elsevierStyleInterRef" href="http://www.nice.org.uk/Guidance/TA162">http&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;Guidance&#47;TA162</a>&#46;"
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Erlotinib in previously treated non-small cell lung cancer"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "F&#46;A&#46; Shepherd"
                            1 => "J&#46; Pereira"
                            2 => "T&#46; Ciuleanu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa050753"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "353"
                        "paginaInicial" => "123"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16014882"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective randomized trial of docetaxel <span class="elsevierStyleItalic">versus</span> best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:1 [
                            0 => "F&#46;A&#46; Shepherd"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/jco.2000.18.10.2095"
                      "Revista" => array:7 [
                        "tituloSerie" => "Journal of Clinical Oncology"
                        "fecha" => "2000"
                        "volumen" => "18"
                        "numero" => "10"
                        "paginaInicial" => "2095"
                        "paginaFinal" => "2103"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10811675"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methods for the economic evaluation of health care programmes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "M&#46; Drummond"
                            1 => "M&#46; Sculpher"
                            2 => "G&#46; Torrance"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:2 [
                        "fecha" => "2005"
                        "editorial" => "Oxford Medical Publications&#59; Third edition"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Letter to the Editor&#58; A comparison of the estimated costs of erlotinib&#44; docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46; Arellano"
                            1 => "C&#46; Leteneux"
                            2 => "W&#46; Kotowa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3111/13696990802113147"
                      "Revista" => array:7 [
                        "tituloSerie" => "Journal of Medical Economics"
                        "fecha" => "2008"
                        "volumen" => "11"
                        "numero" => "2"
                        "paginaInicial" => "363"
                        "paginaFinal" => "370"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19450092"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "lecturaRecomendada" => array:1 [
      0 => array:3 [
        "vista" => "all"
        "titulo" => "<span class="elsevierStyleSectionTitle">Further readings&#47;Leituras adicionais</span>"
        "seccion" => array:1 [
          0 => array:1 [
            "bibliografiaReferencia" => array:2 [
              0 => array:3 [
                "identificador" => "bib16"
                "etiqueta" => "NICE&#44; 2007&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "NICE Technology Appraisal TA124&#46; August 2007&#46; Pemetrexed for the treatment of non-small-cell lung cancer&#46; <a class="elsevierStyleInterRef" href="http://www.nice.org.uk/Guidance/TA124">http&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;Guidance&#47;TA124</a>"
                  ]
                ]
              ]
              1 => array:3 [
                "identificador" => "bib17"
                "etiqueta" => "American&#44; 2006&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "American Pharmaceutical Group criticizes NICE approach <span class="elsevierStyleItalic">vs</span>&#46; Alimta&#58; UK parliamentary Select Committee on Health documents&#58; <a class="elsevierStyleInterRef" href="http://www.publications.parliament.uk/pa/cm200607/cmselect/cmhealth/503/503we06.htm">http&#58;&#47;&#47;www&#46;publications&#46;parliament&#46;uk&#47;pa&#47;cm200607&#47;cmselect&#47;cmhealth&#47;503&#47;503we06&#46;htm</a>&#46;"
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735115/0000001500000003/v1_201305151509/S2173511509701320/v1_201305151509/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9640"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letter to the Editor&#47;Carta ao Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735115/0000001500000003/v1_201305151509/S2173511509701320/v1_201305151509/en/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511509701320?idApp=UINPBA00004E"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803–827
Araújo A, et al. Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células Rev Port Pneumol 2008; 14(6):803–827
Wojciech Bartminski
European Outcomes Research, Health Outcomes Scientist, Oncology & Neuroscience, EMS AREA
Read
836
Times
was read the article
451
Total PDF
385
Total HTML
Share statistics
 array:24 [
  "pii" => "S2173511509701320"
  "issn" => "21735115"
  "doi" => "10.1016/S2173-5115(09)70132-0"
  "estado" => "S300"
  "fechaPublicacion" => "2009-05-01"
  "aid" => "70132"
  "copyright" => "Sociedade Portuguesa de Pneumologia"
  "copyrightAnyo" => "2009"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "cor"
  "cita" => "Rev Port Pneumol. 2009;15:555-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3338
    "formatos" => array:3 [
      "EPUB" => 188
      "HTML" => 1786
      "PDF" => 1364
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2173511509701332"
    "issn" => "21735115"
    "doi" => "10.1016/S2173-5115(09)70133-2"
    "estado" => "S300"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "70133"
    "copyright" => "Sociedade Portuguesa de Pneumologia"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "cor"
    "cita" => "Rev Port Pneumol. 2009;15:560-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3360
      "formatos" => array:3 [
        "EPUB" => 180
        "HTML" => 1807
        "PDF" => 1373
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Ara&#250;jo A&#44; et al&#46; An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "560"
          "paginaFinal" => "566"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Ara&#250;jo A&#44; <span class="elsevierStyleItalic">et al</span>&#46; Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ant&#243;nio Ara&#250;jo"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Ant&#243;nio"
              "apellidos" => "Ara&#250;jo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511509701332?idApp=UINPBA00004E"
    "url" => "/21735115/0000001500000003/v1_201305151509/S2173511509701332/v1_201305151509/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173511509701319"
    "issn" => "21735115"
    "doi" => "10.1016/S2173-5115(09)70131-9"
    "estado" => "S300"
    "fechaPublicacion" => "2009-05-01"
    "aid" => "70131"
    "copyright" => "Sociedade Portuguesa de Pneumologia"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "cor"
    "cita" => "Rev Port Pneumol. 2009;15:553-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2268
      "formatos" => array:3 [
        "EPUB" => 205
        "HTML" => 1127
        "PDF" => 936
      ]
    ]
    "pt" => array:7 [
      "idiomaDefecto" => true
      "titulo" => "Carta ao Editor"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "553"
          "paginaFinal" => "554"
        ]
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Maria Jo&#227;o Marques Gomes"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Maria Jo&#227;o"
              "apellidos" => "Marques Gomes"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511509701319?idApp=UINPBA00004E"
    "url" => "/21735115/0000001500000003/v1_201305151509/S2173511509701319/v1_201305151509/pt/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Ara&#250;jo A&#44; et al&#46; An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "555"
        "paginaFinal" => "559"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Wojciech Bartminski"
        "autores" => array:1 [
          0 => array:3 [
            "preGrado" => "MD MSc"
            "nombre" => "Wojciech"
            "apellidos" => "Bartminski"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "European Outcomes Research&#44; Health Outcomes Scientist&#44; Oncology &#38; Neuroscience&#44; EMS AREA"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Ara&#250;jo A&#44; <span class="elsevierStyleItalic">et al</span>&#46; Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas Rev Port Pneumol 2008&#59; 14&#40;6&#41;&#58;803&#8211;827"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography&#47;Bibliografia"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:15 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:1 [
                            0 => "A&#46; Araujo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Rev Port Pneumol"
                        "fecha" => "2008"
                        "volumen" => "14"
                        "numero" => "6"
                        "paginaInicial" => "803"
                        "paginaFinal" => "827"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19023496"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Peterson P&#44; <span class="elsevierStyleItalic">et al</span>&#46; Is pemetrexed more effective in patients with non-squamous histology&#63; A retrospective analysis of a phase III trial of pemetrexed <span class="elsevierStyleItalic">vs</span>&#46; docetaxel in previously treated patients with advanced nonsmall cell lung cancer &#40;NSCLC&#41;&#46; Abstract P&#35;6521&#44; The European Cancer Conference 2007 &#40;ECCO 14&#41;&#46; Eur J Cancer 2007&#59;5 &#40;Suppl 4&#41;&#58;363&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Drummond M&#44; Sculpher M&#44; Torrance G&#44; <span class="elsevierStyleItalic">et al</span>&#46; Methods for the economic evaluation of health care programmes&#46; Oxford Medical Publications&#59; Third edition&#44; 200&#59; 48-51&#44; 121&#8211;124&#44; 190&#8211;196&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Validity of indirect comparison for estimating efficacy of competing interventions&#58; empirical evidence from published meta-analyses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:1 [
                            0 => "F&#46; Song"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.326.7387.472"
                      "Revista" => array:6 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2003"
                        "volumen" => "326"
                        "numero" => "7387"
                        "paginaInicial" => "472"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12609941"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Indirect comparisons of competing interventions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;M&#46; Glenny"
                            1 => "D&#46;G&#46; Altman"
                            2 => "F&#46; Song"
                            3 => "C&#46; Sakarovitch"
                            4 => "J&#46;J&#46; Deeks"
                            5 => "R&#46; D&#8217;Amico"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Health Technol Assess"
                        "fecha" => "2005"
                        "volumen" => "9"
                        "numero" => "26"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "da Silva AE&#44; <span class="elsevierStyleItalic">et al</span>&#46; Orienta&#231;&#245;es metodol&#243;gicas para estudos de avalia&#231;&#227;o econ&#243;mica de medicamentos&#46; INFARMED 1998 <a class="elsevierStyleInterRef" href="http://www.infarmed.pt/portal/page/portal/infarmed/medicamentos_uso_humano/ava%20liacao_economica_e_comparticipacao/medicamen%20tos_uso_ambulatorio/avaliacao_de_comparticipacao/orien_metodologicas_eaem.pdf">http&#58;&#47;&#47;www&#46;infarmed&#46;pt&#47;portal&#47;page&#47;portal&#47;infarmed&#47;medicamentos&#95;uso&#95;humano&#47;avaliacao&#95;economica&#95;e&#95;comparticipacao&#47;medicamentos&#95;uso&#95;ambulatorio&#47;avaliacao&#95;de&#95;comparticipacao&#47;orien&#95;metodologicas&#95;eaem&#46;pdf</a>&#46;"
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Product Assessment Report &#40;EPAR&#41; and Product Information&#58; Alimta&#46; CHMP 2008 <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/humandocs/Humans/EPAR/al%20imta/alimta.htm">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;Humans&#47;EPAR&#47;al imta&#47;alimta&#46;htm</a>&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Product Assessment Report &#40;EPAR&#41; and Product Information&#58; Tarceva&#46; CHMP 2008 <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/humandocs/Humans/EPAR/tarceva/tarceva.htm">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;Humans&#47;EPAR&#47;tarceva&#47;tarceva&#46;htm</a>&#46;"
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Product Assessment Report &#40;EPAR&#41; and Product Information&#58; Taxotere&#46; CHMP 2008 <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/humandocs/Humans/EPAR/tax%20otere/taxotere.htm">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;Humans&#47;EPAR&#47;tax otere&#47;taxotere&#46;htm</a>&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "N&#46; Hanna"
                            1 => "F&#46;A&#46; Shepherd"
                            2 => "F&#46;V&#46; Fossela"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2004.08.163"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol"
                        "fecha" => "2004"
                        "volumen" => "22"
                        "paginaInicial" => "1589"
                        "paginaFinal" => "1597"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15117980"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "NICE Technology Appraisal TA162&#46; November 2008&#46; Erlotinib for the treatment of non-small cell lung cancer&#46; Pages 11-12 <a class="elsevierStyleInterRef" href="http://www.nice.org.uk/Guidance/TA162">http&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;Guidance&#47;TA162</a>&#46;"
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Erlotinib in previously treated non-small cell lung cancer"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "F&#46;A&#46; Shepherd"
                            1 => "J&#46; Pereira"
                            2 => "T&#46; Ciuleanu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa050753"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "353"
                        "paginaInicial" => "123"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16014882"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective randomized trial of docetaxel <span class="elsevierStyleItalic">versus</span> best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:1 [
                            0 => "F&#46;A&#46; Shepherd"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/jco.2000.18.10.2095"
                      "Revista" => array:7 [
                        "tituloSerie" => "Journal of Clinical Oncology"
                        "fecha" => "2000"
                        "volumen" => "18"
                        "numero" => "10"
                        "paginaInicial" => "2095"
                        "paginaFinal" => "2103"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10811675"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methods for the economic evaluation of health care programmes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "M&#46; Drummond"
                            1 => "M&#46; Sculpher"
                            2 => "G&#46; Torrance"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:2 [
                        "fecha" => "2005"
                        "editorial" => "Oxford Medical Publications&#59; Third edition"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Letter to the Editor&#58; A comparison of the estimated costs of erlotinib&#44; docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46; Arellano"
                            1 => "C&#46; Leteneux"
                            2 => "W&#46; Kotowa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3111/13696990802113147"
                      "Revista" => array:7 [
                        "tituloSerie" => "Journal of Medical Economics"
                        "fecha" => "2008"
                        "volumen" => "11"
                        "numero" => "2"
                        "paginaInicial" => "363"
                        "paginaFinal" => "370"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19450092"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "lecturaRecomendada" => array:1 [
      0 => array:3 [
        "vista" => "all"
        "titulo" => "<span class="elsevierStyleSectionTitle">Further readings&#47;Leituras adicionais</span>"
        "seccion" => array:1 [
          0 => array:1 [
            "bibliografiaReferencia" => array:2 [
              0 => array:3 [
                "identificador" => "bib16"
                "etiqueta" => "NICE&#44; 2007&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "NICE Technology Appraisal TA124&#46; August 2007&#46; Pemetrexed for the treatment of non-small-cell lung cancer&#46; <a class="elsevierStyleInterRef" href="http://www.nice.org.uk/Guidance/TA124">http&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;Guidance&#47;TA124</a>"
                  ]
                ]
              ]
              1 => array:3 [
                "identificador" => "bib17"
                "etiqueta" => "American&#44; 2006&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "American Pharmaceutical Group criticizes NICE approach <span class="elsevierStyleItalic">vs</span>&#46; Alimta&#58; UK parliamentary Select Committee on Health documents&#58; <a class="elsevierStyleInterRef" href="http://www.publications.parliament.uk/pa/cm200607/cmselect/cmhealth/503/503we06.htm">http&#58;&#47;&#47;www&#46;publications&#46;parliament&#46;uk&#47;pa&#47;cm200607&#47;cmselect&#47;cmhealth&#47;503&#47;503we06&#46;htm</a>&#46;"
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735115/0000001500000003/v1_201305151509/S2173511509701320/v1_201305151509/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9640"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letter to the Editor&#47;Carta ao Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735115/0000001500000003/v1_201305151509/S2173511509701320/v1_201305151509/en/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511509701320?idApp=UINPBA00004E"
]
Article information
ISSN: 21735115
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 4 3 7
2024 October 23 29 52
2024 September 28 28 56
2024 August 49 34 83
2024 July 25 25 50
2024 June 19 21 40
2024 May 21 37 58
2024 April 22 17 39
2024 March 20 14 34
2024 February 18 23 41
2024 January 17 28 45
2023 December 13 14 27
2023 November 22 29 51
2023 October 12 30 42
2023 September 15 28 43
2023 August 23 25 48
2023 July 18 27 45
2023 June 13 8 21
2023 May 18 24 42
2023 April 5 7 12
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?